Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma
出版年份 2012 全文链接
标题
Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 106, Issue 10, Pages 1583-1586
出版商
Springer Nature
发表日期
2012-04-18
DOI
10.1038/bjc.2012.144
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mitogen-activated Protein Kinase Kinase 1 (MEK1) Stabilizes MyoD through Direct Phosphorylation at Tyrosine 156 During Myogenic Differentiation
- (2011) Chulman Jo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
- (2011) Tanios Bekaii-Saab et al. JOURNAL OF CLINICAL ONCOLOGY
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
- (2010) Vickie E Baracos et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies
- (2010) Shontelle Dodson et al. Annual Review of Medicine
- Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
- (2010) Xiaolan Zhou et al. CELL
- Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study
- (2010) Sami Antoun et al. JOURNAL OF CLINICAL ONCOLOGY
- Powerful signals for weak muscles
- (2009) Amarjit Saini et al. AGEING RESEARCH REVIEWS
- A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands
- (2009) Jessica R Lieffers et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
- (2009) C. M.M. Prado et al. CLINICAL CANCER RESEARCH
- Update on emerging drugs for cancer cachexia
- (2009) Kate T Murphy et al. EXPERT OPINION ON EMERGING DRUGS
- The role of cytokines in cancer cachexia
- (2009) Josep M Argilés et al. Current Opinion in Supportive and Palliative Care
- A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
- (2008) Marina Mourtzakis et al. Applied Physiology Nutrition and Metabolism
- Cholangiocarcinoma
- (2008) Stefania Mosconi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Inflammatory burden and amino acid metabolism in cancer cachexia
- (2008) William J Durham et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started